Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 222

    1.

    Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins.

    Arutchelvam V, Heise T, Dellweg S, Elbroend B, Minns I, Home PD.

    Diabet Med. 2009 Oct;26(10):1027-32.PMID: 19900235 [PubMed - in process]Related articles

    2.

    Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement Therapy.

    Shakoor SK, Aldibbiat A, Ingoe LE, Campbell SC, Sibal L, Shaw J, Home PD, Razvi S, Weaver JU.

    J Clin Endocrinol Metab. 2009 Nov 6. [Epub ahead of print]PMID: 19897678 [PubMed - as supplied by publisher]Related articles

    3.

    Combined randomised controlled trial experience of malignancies in studies using insulin glargine.

    Home PD, Lagarenne P.

    Diabetologia. 2009 Sep 15. [Epub ahead of print]PMID: 19756478 [PubMed - as supplied by publisher]Related articlesFree article

    4.

    Management of type 2 diabetes: NICE guidelines.

    Sibal L, Home PD.

    Clin Med. 2009 Aug;9(4):353-7. No abstract available. PMID: 19728510 [PubMed - indexed for MEDLINE]Related articles

    5.

    GATA3 is selectively expressed in the trophectoderm of peri-implantation embryo and directly regulates Cdx2 gene expression.

    Home P, Ray S, Dutta D, Bronshteyn I, Larson M, Paul S.

    J Biol Chem. 2009 Oct 16;284(42):28729-37. Epub 2009 Aug 21.PMID: 19700764 [PubMed - in process]Related articles

    6.

    An exploratory study of the effect of using high-mix biphasic insulin aspart in people with type 2 diabetes.

    Dashora U, Ashwell SG, Home PD.

    Diabetes Obes Metab. 2009 Jul;11(7):680-7.PMID: 19527481 [PubMed - in process]Related articles

    7.

    Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

    Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Team.

    Lancet. 2009 Jun 20;373(9681):2125-35. Epub 2009 Jun 6.PMID: 19501900 [PubMed - indexed for MEDLINE]Related articles

    8.

    A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.

    Sibal L, Agarwal SC, Schwedhelm E, Lüneburg N, Böger RH, Home PD.

    Cardiovasc Diabetol. 2009 Jun 1;8:27.PMID: 19486510 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria.

    Sibal L, Aldibbiat A, Agarwal SC, Mitchell G, Oates C, Razvi S, Weaver JU, Shaw JA, Home PD.

    Diabetologia. 2009 Aug;52(8):1464-73. Epub 2009 May 30.PMID: 19484217 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.

    Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD.

    Diabetes Care. 2009 Jul;32(7):1170-6. Epub 2009 Apr 23. Erratum in: Diabetes Care. 2009 Oct;32(10):1944. PMID: 19389820 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Surgery and the prevention of limb loss in diabetes.

    Home PD.

    Br J Surg. 2009 Mar;96(3):227-8. No abstract available. PMID: 19224511 [PubMed - indexed for MEDLINE]Related articles

    12.

    HbA(1c): the case for using estimated average glucose (eAG).

    Home PD.

    Diabet Med. 2008 Aug;25(8):895-8. No abstract available. PMID: 18959600 [PubMed - indexed for MEDLINE]Related articles

    13.

    Tight control of blood glucose and cardiovascular disease.

    Home P.

    BMJ. 2008 Oct 17;337:a2105. doi: 10.1136/bmj.a2105. No abstract available. PMID: 18930973 [PubMed - indexed for MEDLINE]Related articles

    14.

    Impact of the UKPDS--an overview.

    Home PD.

    Diabet Med. 2008 Aug;25 Suppl 2:2-8. Review.PMID: 18717971 [PubMed - indexed for MEDLINE]Related articles

    15.

    A mosaic of RNA binding and protein interaction motifs in a bifunctional mitochondrial tRNA import factor from Leishmania tropica.

    Home P, Mukherjee S, Adhya S.

    Nucleic Acids Res. 2008 Oct;36(17):5552-61. Epub 2008 Aug 28.PMID: 18755708 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Management of type 2 diabetes: summary of updated NICE guidance.

    Home P, Mant J, Diaz J, Turner C; Guideline Development Group.

    BMJ. 2008 Jun 7;336(7656):1306-8. No abstract available. PMID: 18535074 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study).

    Komajda M, Curtis P, Hanefeld M, Beck-Nielsen H, Pocock SJ, Zambanini A, Jones NP, Gomis R, Home PD; RECORD Study Group.

    Cardiovasc Diabetol. 2008 Apr 24;7:10.PMID: 18435852 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes.

    Ashwell SG, Bradley C, Stephens JW, Witthaus E, Home PD.

    Diabetes Care. 2008 Jun;31(6):1112-7. Epub 2008 Mar 13.PMID: 18339977 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Safety of very tight blood glucose control in type 2 diabetes.

    Home P.

    BMJ. 2008 Mar 1;336(7642):458-9. No abstract available. PMID: 18309965 [PubMed - indexed for MEDLINE]Related articles

    20.

    A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.

    Rosenstock J, Davies M, Home PD, Larsen J, Koenen C, Schernthaner G.

    Diabetologia. 2008 Mar;51(3):408-16. Epub 2008 Jan 16.PMID: 18204830 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Rosiglitazone increased heart failure but did not differ from metformin plus sulphonylurea for other CV outcomes at interim analysis.

    Home PD, Pocock SJ, Beck-Nielsen H.

    Evid Based Med. 2007 Dec;12(6):170. No abstract available. PMID: 18063730 [PubMed]Related articles

    22.

    Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents.

    Home PD, Pacini G.

    Diabetes Obes Metab. 2008 Sep;10(9):699-718. Epub 2007 Sep 6. Review.PMID: 17825080 [PubMed - indexed for MEDLINE]Related articles

    23.

    A lifetime modelled economic evaluation comparing pioglitazone and rosiglitazone for the treatment of type 2 diabetes mellitus in the UK.

    Home P, Bagust A, Taylor M, Ambery P, Mendes da Costa S.

    Pharmacoeconomics. 2007;25(9):801-2; author reply 802-5. No abstract available. PMID: 17803338 [PubMed - indexed for MEDLINE]Related articles

    24.

    Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

    Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Group.

    N Engl J Med. 2007 Jul 5;357(1):28-38. Epub 2007 Jun 5.PMID: 17551159 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Rosiglitazone RECORD study: glucose control outcomes at 18 months.

    Home PD, Jones NP, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Komajda M, Curtis P; RECORD Study Group.

    Diabet Med. 2007 Jun;24(6):626-34.PMID: 17517066 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Medical training in the UK: sleepwalking to disaster.

    Brown M, Boon N, Brooks N, Camm J, Corris P, Caulfield M, Chilvers E, Ewan P, Gibson J, Griffin G, Grossman A, Hall A, Hart G, Heagerty T, Hodgson H, Home P, Hughes R, Khaw KT, Lazarus J, Leaper D, Monson J, O'Rahilly S, Rowlands B, Scolding N, Sutton R, Taylor R, Watkins H, Wright N.

    Lancet. 2007 May 19;369(9574):1673-5. No abstract available. PMID: 17512840 [PubMed - indexed for MEDLINE]Related articles

    27.

    Necessary and sufficient factors for the import of transfer RNA into the kinetoplast mitochondrion.

    Mukherjee S, Basu S, Home P, Dhar G, Adhya S.

    EMBO Rep. 2007 Jun;8(6):589-95. Epub 2007 May 18. Erratum in: EMBO Rep. 2009 Jan;10(1):101. PMID: 17510656 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Early retinopathy progression in four randomized trials comparing insulin glargine and NPH [corrected] insulin.

    Davis MD, Beck RW, Home PD, Sandow J, Ferris FL.

    Exp Clin Endocrinol Diabetes. 2007 Apr;115(4):240-3. Erratum in: Exp Clin Endocrinol Diabetes. 2007 Jul;115(7):473. PMID: 17479440 [PubMed - indexed for MEDLINE]Related articles

    29.

    A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes.

    Home PD, Bailey CJ, Donaldson J, Chen H, Stewart MW.

    Diabet Med. 2007 Jun;24(6):618-25. Epub 2007 Apr 2.PMID: 17403121 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Modernising medical careers, medical training application service, and the postgraduate medical education and training board: time for the emperors to don their clothes.

    Brown M, Boon N, Brooks N, Brown E, Camm J, Caulfield M, Chilvers E, Gibson J, Griffin G, Grossman A, Hall A, Hart G, Heagerty T, Home P, Hodgson H, Horton R, Hughes R, Khaw KT, Lazarus J, Leaper D, McCollum P, Monson J, O'Rahilly S, Rowlands B, Scott J, Sutton R, Taylor R, Watkins H, Wright N.

    Lancet. 2007 Mar 24;369(9566):967-8. No abstract available. PMID: 17382804 [PubMed - indexed for MEDLINE]Related articles

    32.

    Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): good for sulfonylureas?

    Al-Ozairi E, Sibal L, Home P.

    Diabetes Care. 2007 Jun;30(6):1677-80. Epub 2007 Mar 10. No abstract available. PMID: 17351288 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial.

    Dashora UK, Sibal L, Ashwell SG, Home PD.

    Diabet Med. 2007 Apr;24(4):344-9. Epub 2007 Jan 12.PMID: 17298589 [PubMed - indexed for MEDLINE]Related articles

    34.

    Cardiovascular risk factors predicting the development of distal symmetrical polyneuropathy in people with type 1 diabetes: A 9-year follow-up study.

    Sibal L, Law HN, Gebbie J, Home P.

    Ann N Y Acad Sci. 2006 Nov;1084:304-18.PMID: 17151310 [PubMed - indexed for MEDLINE]Related articles

    35.

    Predicting the development of macrovascular disease in people with type 1 diabetes: A 9-year follow-up study.

    Sibal L, Law HN, Gebbie J, Dashora UK, Agarwal SC, Home P.

    Ann N Y Acad Sci. 2006 Nov;1084:191-207.PMID: 17151302 [PubMed - indexed for MEDLINE]Related articles

    36.

    The effect of the optimal use of rapid-acting insulin analogues on insulin secretion in Type 2 diabetes.

    Gallagher A, Butler TJ, Home PD.

    Diabetes Res Clin Pract. 2007 Jun;76(3):327-34. Epub 2006 Nov 7.PMID: 17092597 [PubMed - indexed for MEDLINE]Related articles

    37.

    Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.

    Ashwell SG, Gebbie J, Home PD.

    Diabet Med. 2006 Aug;23(8):879-86.PMID: 16911626 [PubMed - indexed for MEDLINE]Related articles

    38.

    An RNA-binding respiratory component mediates import of type II tRNAs into Leishmania mitochondria.

    Chatterjee S, Home P, Mukherjee S, Mahata B, Goswami S, Dhar G, Adhya S.

    J Biol Chem. 2006 Sep 1;281(35):25270-7. Epub 2006 Jul 6.PMID: 16825195 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies.

    Bagust A, Evans M, Beale S, Home PD, Perry AS, Stewart M.

    Pharmacoeconomics. 2006;24 Suppl 1:5-19. Review.PMID: 16800159 [PubMed - indexed for MEDLINE]Related articles

    40.

    Cost-effectiveness of CSII.

    Home PD.

    Diabet Med. 2006 Jun;23(6):707; author reply 707-8. No abstract available. PMID: 16759317 [PubMed - indexed for MEDLINE]Related articles

    41.

    A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes.

    Hermansen K, Davies M, Derezinski T, Martinez Ravn G, Clauson P, Home P.

    Diabetes Care. 2006 Jun;29(6):1269-74. Erratum in: Diabetes Care. 2007 Apr;30(4):1035. PMID: 16732007 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    A bifunctional tRNA import receptor from Leishmania mitochondria.

    Goswami S, Dhar G, Mukherjee S, Mahata B, Chatterjee S, Home P, Adhya S.

    Proc Natl Acad Sci U S A. 2006 May 30;103(22):8354-9. Epub 2006 May 19.PMID: 16714384 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes.

    Ashwell SG, Amiel SA, Bilous RW, Dashora U, Heller SR, Hepburn DA, Shutler SD, Stephens JW, Home PD.

    Diabet Med. 2006 Mar;23(3):285-92.PMID: 16492212 [PubMed - indexed for MEDLINE]Related articles

    44.

    Insulin detemir: from concept to clinical experience.

    Home P, Kurtzhals P.

    Expert Opin Pharmacother. 2006 Feb;7(3):325-43. Review.PMID: 16448327 [PubMed - indexed for MEDLINE]Related articles

    45.

    Identifying the impact of diabetes research.

    Hanney SR, Home PD, Frame I, Grant J, Green P, Buxton MJ.

    Diabet Med. 2006 Feb;23(2):176-84.PMID: 16433716 [PubMed - indexed for MEDLINE]Related articles

    46.

    Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times.

    Ashwell SG, Gebbie J, Home PD.

    Diabet Med. 2006 Jan;23(1):46-52.PMID: 16409565 [PubMed - indexed for MEDLINE]Related articles

    47.

    Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes.

    Home PD, Hallgren P, Usadel KH, Sane T, Faber J, Grill V, Friberg HH.

    Diabetes Res Clin Pract. 2006 Feb;71(2):131-9. Epub 2005 Jul 27.PMID: 16054266 [PubMed - indexed for MEDLINE]Related articles

    48.

    Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol.

    Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Dargie H, Komajda M, Gubb J, Biswas N, Jones NP.

    Diabetologia. 2005 Sep;48(9):1726-35. Epub 2005 Jul 16.PMID: 16025252 [PubMed - indexed for MEDLINE]Related articles

    49.

    A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes.

    Home PD, Rosskamp R, Forjanic-Klapproth J, Dressler A; European Insulin Glargine Study Group.

    Diabetes Metab Res Rev. 2005 Nov-Dec;21(6):545-53.PMID: 16021649 [PubMed - indexed for MEDLINE]Related articles

    50.

    Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes.

    Home P.

    Curr Med Res Opin. 2005 Jul;21(7):989-98. Review.PMID: 16004665 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...